Revicki, D A <br/><br/>
Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients.  [electronic resource] 

 -  American journal of kidney diseases : the official journal of the National Kidney Foundation  Apr 1995 
 - 548-54 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0272-6386 
<br/><br/><label>Standard No.: </label>10.1016/0272-6386(95)90122-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anemia--complications<br/>Erythropoietin--therapeutic use<br/>Female<br/>Hematocrit<br/>Humans<br/>Kidney Failure, Chronic--therapy<br/>Male<br/>Middle Aged<br/>Quality of Life<br/>Recombinant Proteins--therapeutic use